Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,15 CAD | +3,45% | 0,00% | +87,50% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Matheson
CEO | Chief Executive Officer | - | 14/06/21 |
Harry Nijjar
DFI | Director of Finance/CFO | 36 | 01/02/22 |
Mark Williams
PSD | President | 52 | 14/06/21 |
Jacqueline Groot
SEC | Corporate Secretary | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
S. Smallbone
BRD | Director/Board Member | - | 15/02/22 |
Joseph Matheson
CEO | Chief Executive Officer | - | 14/06/21 |
Mark Williams
PSD | President | 52 | 14/06/21 |
Director/Board Member | 55 | 14/06/21 | |
Babak Pedram
BRD | Director/Board Member | 43 | 23/11/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 39 786 231 | 27 910 633 ( 70,15 %) | 0 | 70,15 % |
Coordonnées société
Marvel Biosciences Corp.
505 8th Avenue South West Suite 420
T2P 1G2, Calgary
+
http://www.marvelbiotechnology.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+87,50% | 4,22 M | |
+22,08% | 47,9 Md | |
+46,56% | 41,42 Md | |
-2,44% | 40,7 Md | |
-6,20% | 28,92 Md | |
+10,57% | 25,55 Md | |
-21,29% | 19,27 Md | |
-1,50% | 12,15 Md | |
+31,34% | 12,14 Md | |
-0,64% | 11,99 Md |
- Bourse
- Actions
- Action MRVL
- Société Marvel Biosciences Corp.